Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.
Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G. Rosenstock J, et al. Among authors: koenen c. Diabetologia. 2008 Mar;51(3):408-16. doi: 10.1007/s00125-007-0911-x. Epub 2008 Jan 16. Diabetologia. 2008. PMID: 18204830 Free PMC article. Clinical Trial.
Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
Heller S, Koenen C, Bode B. Heller S, et al. Among authors: koenen c. Clin Ther. 2009 Oct;31(10):2086-97. doi: 10.1016/j.clinthera.2009.10.006. Clin Ther. 2009. PMID: 19922879 Free article. Clinical Trial.
Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study.
Meneghini LF, Rosenberg KH, Koenen C, Merilainen MJ, Lüddeke HJ. Meneghini LF, et al. Among authors: koenen c. Diabetes Obes Metab. 2007 May;9(3):418-27. doi: 10.1111/j.1463-1326.2006.00674.x. Diabetes Obes Metab. 2007. PMID: 17391170
Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE.
Dornhorst A, Lüddeke HJ, Koenen C, Meriläinen M, King A, Robinson A, Sreenan S; PREDICTIVE Study Group. Dornhorst A, et al. Among authors: koenen c. Diabetes Obes Metab. 2008 Jan;10(1):75-81. doi: 10.1111/j.1463-1326.2007.00816.x. Epub 2007 Nov 22. Diabetes Obes Metab. 2008. PMID: 18034846
Response to Swinnen et al.
Moses AC, Koenen C. Moses AC, et al. Among authors: koenen c. Diabetes Technol Ther. 2010 Jun;12(6):503-5. doi: 10.1089/dia.2009.0186. Diabetes Technol Ther. 2010. PMID: 20470235 Free PMC article. No abstract available.
19 results